Cytopenia in autosomal dominant polycystic kidney disease (ADPKD): merely an association or a disease-related feature with prognostic implications?
- 27 January 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Pediatric Nephrology
- Vol. 36 (11), 1-10
- https://doi.org/10.1007/s00467-021-04937-9
Abstract
Autosomal dominant polycystic kidney disease (ADPKD) is associated with distinct cytopenias in observational studies; the most consistent and strongest association is seen with alternations in the lymphocytic lineages. Although the underlying mechanism of these associations is unclear, it has been hypothesized to be secondary to sequestration of white blood cells in cystic organs, or related to the uremic environment in chronic kidney disease (CKD). However, since mutations in PKD1 or -2 affect several immunomodulating pathways, cytopenia may well be an unrecognized extrarenal manifestation of ADPKD. Furthermore, many important questions on the clinical implications of this finding and the effect on the disease course in these patients are unanswered. In this review article, we provide an overview of the current evidence on cytopenia in ADPKD and explore the underlying mechanisms of this association and its potential prognostic implications. Based on the current literature, we hypothesize that polycystin deficiency can disturb immune cell homeostasis and that cytopenia is thus an intrinsic feature of ADPKD, related to genetic factors. Taken together, these findings warrant further investigation to establish the exact etiology and role of cytopenia in patients with ADPKD.Keywords
This publication has 50 references indexed in Scilit:
- Immune Dysfunction in Uremia—An UpdateToxins, 2012
- Polycystin-1 regulates STAT activity by a dual mechanismProceedings of the National Academy of Sciences of the United States of America, 2011
- CiliopathiesThe New England Journal of Medicine, 2011
- Outcomes of renal transplantation in patients with autosomal dominant polycystic kidney disease: a nationwide longitudinal studyTransplant International, 2011
- Emerging evidence of a link between the polycystins and the mTOR pathwaysPathoGenetics, 2009
- Calcimimetic Inhibits Late-Stage Cyst Growth in ADPKDJournal of the American Society of Nephrology, 2009
- Deficiency of polycystin‐2 reduces Ca2+channel activity and cell proliferation in ADPKD lymphoblastoid cellsThe FASEB Journal, 2004
- Caspases, Bcl-2 proteins and apoptosis in autosomal-dominant polycystic kidney diseaseKidney International, 2002
- Polycystin Expression in the Kidney and Other Tissues: Complexity, Consensus and ControversyNephron Experimental Nephrology, 2000
- Effects of calcium channel modulators on the proliferation of mouse spleen lymphocytesin vitroInflammation Research, 1990